Rats treated with sitagliptin had decreased precancerous lesions and reactive oxygen species in a colon cancer in vivo model [12], and DPP4 inhibition with sitagliptin suppressed tumour growth in a 4T1 syngeneic model of breast cancer [42]. Here, DPP4 is linked to colonic neoplasm.